Medline Inc(MDLN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 6:17 PM ET (Korea 9/12 07:17)
Full metrics table
| Index | - | P/E | 38.14 | EPS (ttm) | 0.85 | Insider Own | 41.89% | Shs Outstand | 877.0M | Perf Week | -11.1% |
| Market Cap | 42.77B | Forward P/E | 20.69 | EPS next Y | 5.32% | Insider Trans | -34.44% | Shs Float | 509.8M | Perf Month | -8.37% |
| Enterprise Value | 60.23B | PEG | 2.63 | EPS next Q | 0.35 | Inst Own | 74.08% | Short Float | 7.74% | Perf Quarter | -12.39% |
| Income | 0.69B | P/S | 1.43 | EPS this Y | 4.32% | Inst Trans | 10.39% | Short Ratio | 5.16 | Perf Half Y | -20.79% |
| Sales | 29.94B | P/B | 2.47 | EPS next 5Y | 7.87% | ROA | 1.83% | Short Interest | 39.48M | Perf YTD | -22.55% |
| Book/sh | 13.19 | P/C | 15.96 | EPS past 3/5Y | - | ROE | 4.86% | 52W High | -36.06% ($50.88) | Perf Year | - |
| Cash/sh | 2.04 | P/FCF | 27.66 | Sales past 3/5Y | 9.85% - | ROIC | 2.87% | 52W Low | 0.74% ($32.29) | Perf 3Y | - |
| Dividend Est. | $0.04 (0.13%) | EV/EBITDA | 20.27 | EPS Y/Y TTM | -46.11% | Gross Margin | 23.85% | Volatility(W/M) | 4.21% 3.64% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 2.01 | Sales Y/Y TTM | 12.12% | Oper. Margin | 6.5% | ATR (14) | 1.45 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.61 | EPS Q/Q | -83.26% | Profit Margin | 2.31% | RSI (14) | 36.96 | Recom | 1.59 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.33 | Sales Q/Q | 11.6% | SMA20 | -6.2% ($34.68) | Beta | - | Target Price | $44.58 |
| Payout | - | Debt/Eq | 1.09 | Earnings | 2026/8/5 | SMA50 | -12.71% ($37.27) | Rel Volume | 0.59 | Prev Close | $32.39 |
| Employees | 45000 | LT Debt/Eq | 1.08 | EPS/Sales Surpr. | 41.88% 2.21% | SMA200 | -20.4% ($40.87) | Avg Volume(3M) | 7.65M | Price | $32.53 |
| IPO | 2025/12/17 | Option/Short | Yes/Yes | Trades | 34651 | Volume | 4,515,908 | Change | 0.43% |
Company
MDLN is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A global healthcare supply chain company operating in medical supplies, devices, and medical distribution businesses. Founded in the United States in 1966 and headquartered in Northfield, Illinois, it broadly supplies hospitals, nursing homes, and outpatient clinics with medical consumables and its own branded products.
Over the past 1 year, on the lower side
36% below its 1-year high.
MDLN makes money exceptionally well
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +4.3% this year.
Tap to view numbers
The price looks about right
Trading at 38.1 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Long-term returns are close to the market
Tap to view numbers
The dividend is on the small side
Pays 0.13% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 74.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IPO 0.05%
NMB 0.03%
FPX 0.03%
XHE 0.02%
LYTE 0.01%It ranks #3 in the industry
Based on market cap of $43B.
MDLN $43B PER 38.1
ISRG $131B PER 42.4
BDX $48B PER 53.6
ALC $32B PER 50.6
FAQ
What kind of company is MDLN?
MDLN belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of MDLN?
The market cap of MDLN is approximately $42.8B, ranking 368 within its sector.
Does MDLN pay dividends?
MDLN has a dividend yield of approximately 0.13%, with an annual dividend of $0.04.
What is the P/E ratio of MDLN?
MDLN has a P/E ratio of approximately 38.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for MDLN?
MDLN has recorded a 52-week high of $50.88 and a low of $32.29.
